Study of Neuro-Cognitive Correlates of Pediatric Anxiety Disorders
NCT00018057
This study is recruiting at 2 US sites in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
Study Description: This study examines relations between neurocognitive and clinical features of pediatric anxiety disorders. The study uses neuro-cognitive tasks, functional magnetic resonance imaging (fMRI), as well as magneto- and electro-encephalography (M/EEG). Patients will be studied over one year, before and after receiving either one of two standard-of-care treatments: cognitive behavioral therapy (CBT) or fluoxetine, a serotonin reuptake inhibitor (SSRI). Healthy comparisons will be studied at comparable time points.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Anxiety Disorders
- Major Depressive Disorder
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 2
- Ages
- 8 to 65 years
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- National Institute of Mental Health (NIMH)
- Last updated on ClinicalTrials.gov
- September 22, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Maryland · 2
- National Institutes of Health Clinical Center · Bethesda, MD
- University of Maryland, College Park · College Park, MD
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.